These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3132439)

  • 21. [Development of resistance in imipenem therapy in Pseudomonas aeruginosa].
    Krech T; Naumann P
    Immun Infekt; 1986 Nov; 14(6):224-6. PubMed ID: 3100426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of imipenem and other antibiotics into inflammatory exudate and their efficacy in pseudomonas infection in the rat granuloma pouch model.
    Hashizume T; Okumoto Y; Ogashiwa M; Shimano K
    J Antimicrob Chemother; 1987 Sep; 20(3):413-6. PubMed ID: 3119555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin.
    Bryant RE; Mazza JA
    Am J Med; 1989 Nov; 87(5A):23S-27S. PubMed ID: 2589367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
    Blahová J; Králiková K; Krcméry V; Mlynarcík D; Trupl J
    Acta Virol; 1997 Oct; 41(5):293-6. PubMed ID: 9607084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Solak S; Willke A; Ergönül O; Tekeli E
    Int J Antimicrob Agents; 2005 Feb; 25(2):181-2. PubMed ID: 15664492
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative imipenem treatment of Staphylococcus aureus endocarditis in the rat.
    Baumgartner JD; Glauser MP
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():79-87. PubMed ID: 6583198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G; Pozzetto B; Dorche G
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.
    Yadav R; Bulitta JB; Wang J; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance emergence among P. aenrginosa in a rat thigh-abscess model. Comparison of imipenem and meropenem treatment.
    Karadenizli A; Kolayli F; Okay E; Ergen K; Oz S; Savli H; Leblebicioglu H; Vahaboglu H
    New Microbiol; 2003 Jul; 26(3):275-80. PubMed ID: 12901424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical monotherapy with meropenem or combination therapy: the microbiological point of view.
    Garcinuño P; Santibañez M; Gimeno L; Sánchez-Bautista A; Coy J; Sánchez-Paya J; Boix V; Merino E; Portilla J; Rodríguez JC
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1851-1855. PubMed ID: 27503076
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Killing" of pseudomonas aeruginosa isolated from patients with critical post-operative complications. Effect of various antibiotics].
    Delogu G; Iona E; Amati F; Marandola M; Costantini D; Baumgartner IM; Mascellino MT
    Ann Ital Chir; 1997; 68(2):219-24. PubMed ID: 9290013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Weinstein RA; Nathan C; Delzell D; Kabins SA
    Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal effects of antimicrobial agents on epithelial cell-associated Pseudomonas aeruginosa.
    Hirakata Y; Yano H; Arai K; Kitagawa M; Hatta M; Kunishima H; Kaku M
    J Infect Chemother; 2012 Jun; 18(3):347-51. PubMed ID: 22116462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin.
    Mikura S; Wada H; Okazaki M; Nakamura M; Honda K; Yasutake T; Higaki M; Ishii H; Watanabe T; Tsunoda T; Goto H
    J Hosp Infect; 2011 Nov; 79(3):267-8. PubMed ID: 21864937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.
    Ingerman MJ; Pitsakis PG; Rosenberg AF; Levison ME
    J Infect Dis; 1986 Apr; 153(4):707-14. PubMed ID: 2936832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of subinhibitory concentrations of Ciprofloxacin and gentamicin on the adherence of Pseudomonas aeruginosa to Vero cells and voided uroepithelial cells.
    Zhanel GG; Kim SO; Davidson RJ; Hoban DJ; Nicolle LE
    Chemotherapy; 1993; 39(2):105-11. PubMed ID: 8458242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activity of gentamicin and N-formimidoyl thienamycin (MK 0787) on Pseudomonas aeruginosa at pH 7.4 and 7.0.
    Corrado ML; Cherubin CE; Shulman M; Moen J; Jhagroo M
    J Antimicrob Chemother; 1981 Jun; 7(6):677-80. PubMed ID: 6788748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.